Sign in to view content

Percentage of Patients Maintained on Quarterly Anti-VEGF Dosing for the Treatment of Neovascular Age-Related Macular Degeneration

David A. Eichenbaum, MD, FASRS

Video
Published 2018

Related

Predictors of As-Needed Ranibizumab Injection Frequency in Patients With Macular Edema Following Retinal Vein Occlusion
Glenn C. Yiu, MD, PhD
Annual Meeting Talks
2021
Patients Ultra-Responsive to Ranibizumab (RBZ): Rates of >4-Step Improvement in Diabetic Retinopathy Severity in DRCR.net Protocol S
Allen Chiang, MD, FASRS
Updates from the Field
2019
Real-World Treatment Patterns in Patients With Macular Edema Due to Retinal Vein Occlusion
Vrinda S. Hershberger, MD, PhD
Annual Meeting Talks
2020

Category: AMD-Neovascular

Anti-VEGF

See more